| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $42K | -76.8% |
| Cost of Revenue | $42K | -75.6% |
| Gross Profit | $0 | -100.0% |
| R&D Expense | $6.0M | +33.5% |
| SG&A Expense | $398K | +17.1% |
| Operating Income | -$11.5M | -20.3% |
| Pre-tax Income | -$11.4M | -20.1% |
| Income Tax | $0 | -100.0% |
| Net Income | -$11.4M | -19.9% |
| EPS (Basic) | $0.25 | +0.0% |
| EPS (Diluted) | $0.25 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | -17.9% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $15.3M | +70.5% |
| Total Assets | $16.0M | +70.3% |
| Current Liabilities | $2.2M | +87.3% |
| Total Liabilities | $2.9M | +120.8% |
| Stockholders' Equity | $13.1M | +62.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | -8.1% |
| Capital Expenditures | $107K | +3466.7% |
| Investing Cash Flow | -$107K | -3466.7% |
| Financing Cash Flow | $13.7M | +206.3% |
| Free Cash Flow | -$7.5M | -9.6% |